Corrigendum: Targeted therapy in cardiovascular disease: A precision therapy era

Corrigendum: Targeted therapy in cardiovascular disease: A precision therapy era

Bibliographic Details
Main Authors:	Mengda Xu, Kailun Zhang, Jiangping Song
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Series:	Frontiers in Pharmacology
Subjects:	targeted therapy antibody gene editing nucleic acid drugs cell therapy cardiovascular disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1145460/full

Similar Items

Targeted Therapy in Cardiovascular Disease: A Precision Therapy Era
by: Mengda Xu, et al.
Published: (2021-04-01)

Gene editing therapy ready for cardiovascular diseases: opportunities, challenges, and perspectives
by: Zhou Jun, et al.
Published: (2021-10-01)

Gene Therapy for Cardiovascular Disease: Basic Research and Clinical Prospects
by: Genmao Cao, et al.
Published: (2021-11-01)

Corrigendum: Targeted Gene Delivery: Where to Land
by: Giulia Pavani, et al.
Published: (2021-05-01)

HER2-targeted therapies in cancer: a systematic review
by: Kunrui Zhu, et al.
Published: (2024-02-01)

Advances in Cardiovascular Toxicity Associated with Targeted Therapy for Breast Cancer
by: WANG Yan, et al.
Published: (2021-05-01)

Polymer Nanoparticles and Nanomotors Modified by DNA/RNA Aptamers and Antibodies in Targeted Therapy of Cancer
by: Veronika Subjakova, et al.
Published: (2021-01-01)

Nucleic acid nanostructure for delivery of CRISPR/Cas9‐based gene editing system
by: Wantao Tang, et al.
Published: (2023-01-01)

Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
by: Qi Chang Zheng, et al.
Published: (2021-02-01)

The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively
by: Wen‐Qian Li, et al.
Published: (2021-07-01)

Targeting the Apoa1 locus for liver-directed gene therapy
by: Marco De Giorgi, et al.
Published: (2021-06-01)

Nanomaterial-Based Drug Targeted Therapy for Cardiovascular Diseases: Ischemic Heart Failure and Atherosclerosis
by: Mihai Ștefan Cristian Haba, et al.
Published: (2021-09-01)

Photodynamic Therapy: Targeting Cancer Biomarkers for the Treatment of Cancers
by: Xinning Wang, et al.
Published: (2021-06-01)

Targeted Therapies in Advanced and Metastatic Urothelial Carcinoma
by: Andrew B. Katims, et al.
Published: (2022-11-01)

Utilization and Potential of RNA-Based Therapies in Cardiovascular Disease
by: Emma Louise Robinson, MS, PhD, et al.
Published: (2022-09-01)

Pancreatic Cancer: Nucleic Acid Drug Discovery and Targeted Therapy
by: Hong Dai, et al.
Published: (2022-05-01)

Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
by: Ying Zhang, et al.
Published: (2022-06-01)

Nanotechnology Lighting the Way for Gene Therapy in Ophthalmopathy: From Opportunities toward Applications
by: Weiming Ren, et al.
Published: (2023-04-01)

Research Progress on Gene Editing Based on Nano-Drug Delivery Vectors for Tumor Therapy
by: Shiwen Xi, et al.
Published: (2022-03-01)

Targeted Gene Therapy of Cancer: Second Amendment toward Holistic Therapy
by: Jaleh Barar, et al.
Published: (2013-02-01)

Progress of nucleic acid drugs and non-viral carriers in gene therapy
by: LIU Jian
Published: (2022-01-01)

Advances in targeted therapy for pancreatic cancer
by: Lin Xing, et al.
Published: (2023-12-01)

Functional Nucleic‐Acid‐Decorated Spherical Nanoparticles: Preparation Strategies and Current Applications in Cancer Therapy
by: Min Zhu, et al.
Published: (2021-03-01)

Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis
by: Mathieu Ferrari, et al.
Published: (2021-02-01)

HER3 signaling and targeted therapy in cancer
by: Rosalin Mishra, et al.
Published: (2018-05-01)

Carrier strategies boost the application of CRISPR/Cas system in gene therapy
by: Zunkai Xu, et al.
Published: (2022-04-01)

Editorial: Nucleic acid-based therapies for cardiovascular diseases
by: Fabio Martelli, et al.
Published: (2024-03-01)

Antibody-drug conjugates: the paradigm shifts in the targeted cancer therapy
by: Devesh Aggarwal, et al.
Published: (2023-08-01)

Gene Therapies for Monogenic Autism Spectrum Disorders
by: Wout Weuring, et al.
Published: (2021-10-01)

Ionizable drug delivery systems for efficient and selective gene therapy
by: Yu-Qi Zhang, et al.
Published: (2023-02-01)

The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
by: Qing Wei, et al.
Published: (2024-01-01)

Current Status of Targeted Therapy for Biliary Tract Cancer in the Era of Precision Medicine
by: Takafumi Mie, et al.
Published: (2024-02-01)

Genome-wide Specificity of Highly Efficient TALENs and CRISPR/Cas9 for T Cell Receptor Modification
by: Friederike Knipping, et al.
Published: (2017-03-01)

Novel insights into cardiovascular toxicity of cancer targeted and immune therapies: Beyond ischemia with non-obstructive coronary arteries (INOCA)
by: Firas Kreidieh, et al.
Published: (2024-04-01)

Neoglycoconjugates for the delivery of nucleic acids into eucaryotic cells
by: M. A. Maslov, et al.
Published: (2015-08-01)

Editorial: Targeted cancer therapies, from small molecules to antibodies, volume II
by: Chao-Yue Su, et al.
Published: (2023-06-01)

Recent Advance of Liposome Nanoparticles for Nucleic Acid Therapy
by: Yongguang Gao, et al.
Published: (2023-01-01)

Aptamers and antibodies: rivals or allies in cancer targeted therapy?
by: Lisa Agnello, et al.
Published: (2021-02-01)

A radiologist’s guide to novel anticancer therapies in the era of precision medicine
by: Ali Khader, et al.
Published: (2022-01-01)

Recent developments in receptor tyrosine kinases targeted anticancer therapy
by: Samir H. Raval, et al.
Published: (2016-01-01)